Epizyme, Inc.
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS
Last updated:
Abstract:
The present invention relates to substituted purine and 7-deazapurine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer and neurological disorders, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Status:
Application
Type:
Utility
Filling date:
10 Jun 2020
Issue date:
19 Aug 2021